HuagongsheHuagongshe Chemistry Print Report · For research reference only
Piperazine → HCID 44609033, compound
Participants
| Role | Name | HCID | Charge |
|---|---|---|---|
| Reactant | Piperazine | HCID 4837 | — |
| Reactant | Lithium Bromide | HCID 82050 | — |
| Reactant | HCID 66936604 | HCID 66936604 | — |
| Solvent | Dimethylformamide | HCID 6228 | — |
| Product | HCID 44609033 | HCID 44609033 | — |
Reaction Steps
By the same method as in the step d) of Example 45, (3,5-dibromo-4-methoxy-phenyl)-[7-(3-trifluoromethyl-phenyl)-2,3-dihydro-pyrido[2,3-b][1,4]oxazin-1-yl]-methanone (165 mg, 0.29 mmol), lithium bromide (100 mg, 1.15 mmol) and piperazine (37.3 mg, 0.43 mmol) were dissolved in N,N-dimethyl formamide (2 ml) and reacted at 100□ to obtain the target compound 63, i.e., (3,5-dibromo-4-hydroxy-phenyl)-[7-(3-trifluoromethyl-phenyl)-2,3-dihydro-pyrido[2,3-b][1,4]oxazin-1-yl]-methanone, as white solid (90 mg, 56%).
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|---|
| Patent number | US08394792B2 |
| Source dataset | uspto-grants-2013_03 |
| ORD ID | ord-24567c5e7d0d40b0b17375c51d54adc6 |
| Source note | uspto-grants-2013_03 |